Download PDF
Semin Thromb Hemost 2000; Volume 26(Number 03): 325-334
DOI: 10.1055/s-2000-8474
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Hyperhomocysteinemia and Risk of Vascular Disease in Women

PETRA. VERHOEF
  • Wageningen Center for Food Sciences and Wageningen University, Wageningen, The Netherlands
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

Plasma levels of total homocysteine (tHcy), a possible risk factor for vascular disease, are generally lower in women than in men and lower in premenopausal women than in postmenopausal women. This article reviews studies that have investigated associations of hyperhomocysteinemia with risk of vascular disease among women or that compared risk by stratum of gender or menopausal status.

Seven out of 12 epidemiological studies that included both men and women found hyperhomocysteinemia to be a stronger risk factor in women than in men. However, the interaction effect was statistically significant for only 1 study. Three studies observed no risk difference between men and women, and 2 observed a weaker association in women. In addition, 3 studies that consisted (almost) entirely of women observed direct associations of hyperhomocysteinemia with vascular disease risk, comparable to associations observed in male populations. Hyperhomocysteinemia was associated with increased risk in populations of both young and elderly women, but only few studies have compared risks among premenopausal and postmenopausal women. However, the limited data indicate that hyperhomocysteinemia is also associated with elevation of vascular disease risk before the menopause.

The stronger association among women in some studies may be explained by aspects of the study design, such as age at inclusion (i.e., women usually suffer from vascular diseases later in life than do men), or aspects of the data analysis, such as use of an overall instead of a gender-specific cutoff point. Of course, one cannot exclude the possibility that women are somehow more susceptible to detrimental effects of tHcy than men are, although there is evidence from other studies that estrogens have a ``protective'' effect on the vascular wall and a favorable effect on hemostasis.

In conclusion, we should consider hyperhomocysteinemia as a potential risk factor for vascular disease in both men and women, before and after the menopause.

KEYWORD

Hyperhomocysteinemia - vascular disease - gender - menopause - estrogen

REFERENCES

  • 1 Boushey C J, Beresford S AA, Omenn G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.  JAMA . 1995;  274 1049-1057
    Google Scholar
  • 2 Refsum H, Ueland P M, Nygård O, Vollset M D. Homocysteine and cardiovascular disease.  Annu Rev Med . 1998;  49 31-62
    CrossrefPubMedGoogle Scholar
  • 3 Selhub J, Jacques P F, Wilson P WF, Rush D, Rosenberg I H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.  JAMA . 1993;  270 2693-2698
    CrossrefPubMedGoogle Scholar
  • 4 Jacobsen D W, Gatautis V J, Green R. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects.  Clin Chem . 1994;  40 873-881
    PubMedGoogle Scholar
  • 5 Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects.  J Intern Med . 1994;  236 633-641
    PubMedGoogle Scholar
  • 6 Nygård O, Vollset S E, Refsum H et. Total plasma homocysteine and cardiovascular risk profile: The Hordaland homocysteine study.  JAMA . 1995;  274 1526-1533
    CrossrefPubMedGoogle Scholar
  • 7 Lussier-Cacan S, Xhignesse M, Piolot A. Plasma total homocysteine in healthy subjects: Sex specific relation with biological traits.  Am J Clin Nutr . 1996;  64 587-583
    PubMedGoogle Scholar
  • 8 Andersson A, Brattström L, Israelsson B. Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status.  Eur J Clin Invest . 1992;  22 79-87
    PubMedGoogle Scholar
  • 9 Kang S S, Wong P W, Cook H Y, Norusis M, Messer J V. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.  J Clin Invest . 1986;  77 1482-1486
    PubMedGoogle Scholar
  • 10 Verhoef P, Meleady R, Daly L E. Homocysteine, vitamin status and risk of vascular disease: Effects of gender and menopausal status.  Eur Heart J . 1999;  20 1234-1244
    CrossrefPubMedGoogle Scholar
  • 11 Boers G H, Smals A G, Trijbels F J, Leermakers A I, Kloppenborg P W. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years.  J Clin Invest . 1983;  72 1971-1976
    PubMedGoogle Scholar
  • 12 Brattström L E, Hultberg B L, Hardebo J E. Folic acid responsive post-menopausal homocysteinemia.  Metabolism . 1985;  34 1073-1077
    CrossrefPubMedGoogle Scholar
  • 13 Blom H J, Boers G H, Van den Elzen J P. Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease .  Eur J Clin Invest . 1988;  18 633-638
    PubMedGoogle Scholar
  • 14 Wouters M GAJ, Moorrees MThEC, Van der Mooren M J. Plasma homocysteine and menopausal status.  Eur J Clin Invest . 1995;  25 801-805
    PubMedGoogle Scholar
  • 15 Gensini G F, Micheli S, Prisco D, Abbate R. Menopause and risk of cardiovascular disease.  Thromb Res . 1996;  84 1-19
    CrossrefPubMedGoogle Scholar
  • 16 Malinow M R, Nieto J N, Szklo M, Chambless L E, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.  Circulation . 1993;  87 1107-1113
    PubMedGoogle Scholar
  • 17 Selhub J, Jacques P F, Bostom A G. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.  N Engl J Med . 1995;  332 286-291
    CrossrefPubMedGoogle Scholar
  • 18 Aronow W S, Ahn C. Association between plasma homocysteine and coronary artery disease in older persons.  Am J Cardiol . 1997;  80 1216-1218
    CrossrefPubMedGoogle Scholar
  • 19 Robinson K, Mayer E L, Miller D P. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.  Circulation . 1995;  92 2825-2830
    PubMedGoogle Scholar
  • 20 Hopkins P N, Wu L L, Wu J. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease.  Arterioscler Thromb Vasc Biol . 1995;  15 1314-1320
    PubMedGoogle Scholar
  • 21 Den Heijer M, Koster T, Blom H J. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.  N Engl J Med . 1996;  334 759-762
    Google Scholar
  • 22 Schwartz S M, Siscovich D S, Malinow M R. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene .  Circulation . 1997;  96 412-417
    PubMedGoogle Scholar
  • 23 Alfthan G, Pekkanen J, Jauhiainen M. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.  Atherosclerosis . 1994;  106 9-19
    CrossrefPubMedGoogle Scholar
  • 24 Petri M, Roubenoff R, Dallal G E. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.  Lancet . 1996;  348 1120-1124
    CrossrefPubMedGoogle Scholar
  • 25 Nygård O, Nordrehaug J E, Refsum H. Plasma homocysteine levels and mortality in patients with coronary artery disease.  N Engl J Med . 1997;  337 230-236
    CrossrefPubMedGoogle Scholar
  • 26 Folsom A R, Nieto F J, McGovern P G. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins.  The Atherosclerosis Risk in Communities (ARIC) Study. Circulation . 1998;  98 204-210
    PubMedGoogle Scholar
  • 27 Bostom A G, Rosenberg I H, Silbershatz H. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study.  Ann Intern Med . 1999;  131 352-355
    PubMedGoogle Scholar
  • 28 Bots M L, Launer L J, Lindemans J. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.  Arch Intern Med . 1999;  159 38-44
    CrossrefPubMedGoogle Scholar
  • 29 Ridker P M, Manson J E, Buring J E. Homocysteine and risk of cardiovascular disease among postmenopausal women .  JAMA . 1999;  281 1817-1821
    CrossrefPubMedGoogle Scholar
  • 30 Stampfer M J, Malinow M R, Willett W C. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.  JAMA . 1992;  268 877-881
    CrossrefPubMedGoogle Scholar
  • 31 Chasan-Taber L, Selhub J, Rosenberg I H. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.  J Am Coll Nutr . 1996;  15 136-143
    PubMedGoogle Scholar
  • 32 Dudman N PB, Wilcken D EL, Wang J. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.  Arterioscler Thromb . 1993;  13 1253-1260
    PubMedGoogle Scholar
  • 33 Boers G. Refinement of the methionine loading test. In: Robinson K, ed. Homocysteinemia and Vascular Disease. Proceedings of an EC COMAC-Epidemiology Expert Group Workshop Luxembourg: Commission of the European Communities, 1990: 61-66
    Google Scholar
  • 34 Silberberg J, Crooks R, Fryer J. Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading.  Atherosclerosis . 1997;  133 105-110
    CrossrefPubMedGoogle Scholar
  • 35 Graham I H, Daly L E, Refsum H M. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project.  JAMA . 1997;  277 1775-1781
    CrossrefPubMedGoogle Scholar
      >